Journal of Internal Medicine 1998: Vol 243 Index

11 Pages·1998·2 MB·English

Journal of Internal Medicine 1998; 243: 595-599
Author index
Abdelnoor M see Reikvam A et al. Canova CR, Kuhn M, Allemann J, Reinhart WH. Lethal pulmonary
Aberg H see Asplund R hypertension in a young woman caused by unrecognized
Addolorato G see Capristo Ee t al. haemangiosis carcinomatosa (Case report), 255
Agarwal SK see Guru SC et al. Capristo E, Mingrone G, Addolorato G, Greco AV, Gasbarrini G.
Agarwal SK see Marx SJ et al. Metabolic features of inflammatory bowel disease in a remis-
Ahrén B see Florén C-H et al. sion phase of the disease activity, 339
Allemann J see Canova CR et al. Cardoso EMP, Stal P, Hagen K, Cabeda JM, Esin S, De Sousa M,
Anderson DR see Wells PS et al. Hultcrantz R. HFE mutations in patients with hereditary
Ando Ms ee Yoshimatsu S-I et al. haemochromatosis in Sweden, 203
Ando Ys ee Yoshimatsu S-I et al. Carlomagno F see Santoro M et al.
Archimandritis A, Souyioultzis S, Katsorida M, Tzivras M. Carney JA. Familial multiple endocrine neoplasia syndromes: com-
Clostridium difficile colitis associated with a ‘triple’ regimen, ponents, classification, and nomenclature (Minisymposium),
containing clarithromycin and metronidazole, to eradicate 425
Helicobacter pylori (Case report), 251 Ceccherini I see Romeo G et al.
Argiris A see Gould D Celli J see Romeo G et al.
Artner-Dworzak E see Samsonov M et al. Choo KE see Davis TME et al.
Asai N see Takahashi M et al. Chrousos GP, Stratakis CA. Carney complex and the familial lentig-
Asplund R, Aberg H. Sleep and cardiac symptoms amongst inosis syndromes: link to inherited neoplasias and develop-
women aged 40-64 years, 209 mental disorders, and genetic loci (Minisymposium), 573
Cieslar E see Hruby Z et al.
Bartosik J see Florén C-H et al. Cogo A see Wells PS et al.
Bavenholm P see Regnstrém J et al. Cohen DJ see Beattie JR et al.
Beattie JR, Cohen DJ, Manning WJ, Douglas PS. Role of routine Crabtree JS see Guru SC et al.
transthoracic echocardiography in evaluation and manage-
ment of stroke, 281 D'Ovidio R see Wells PS et al.
Belenkov J see Samsonov M et al. Dahlen GH see Weinehall L et al.
Bender BU see Neumann HPH Davis TME, Singh B, Choo KE, Ibrahim J, Sulaiman SA, Kadir ZA,
Bender R see Sawicki PT et al. Ismail R. Dynamic assessment of parathyroid function in
Bengtsson K see Bog-Hansen Ee t al. acute malaria, 349
Bengtsson M see Florén C-H et al de Faire U see Regnstrém J et al.
Berge RK see Nordoy A et al. de Herder WW see Lamberts SWJ et al.
Bergenfelz A see Valdemarsson Se t al. De Marzio P see Sgreccia A et al.
Berger M see Sawicki PT et al. De Sousa M see Cardoso EMP et al.
Berger M see Sawicki PT De Vincentis G see Sgreccia A et al.
Berglin Blohm M, Hartford M, Karlsson T, Herlitz J. Factors associ- De Vita G see Santoro M et al.
ated with pre-hospital and in-hospital myocardial infarction: Debelenko LV see Guru SC et al.
a 6-year experience, 243 Debenedetti MK see Moley JF et al.
Berglund G see Endre T et al. Dilley WG see Moley JF et al.
Berntorp E, Berntorp K, Brorson H, Frick K. Liposuction in Douglas PS see Beattie JR et al.
Dercum’s disease: impact on haemostatic factors associated Drory Y see Lev EI et al.
with cardiovascular disease and insulin sensitivity, 197 Dulawa J see Hruby Z et al.
Berntorp K see Berntorp E et al.
Betsos N see Romeo G et al. Egermayer P. Hyperthyroidism and pulmonary hypertension
Bog-Hansen E, Lindblad U, Bengtsson K, Ranstam J, Melander A, (Letter to the Editor), 398
Rastam L. Risk factor clustering in patients with hypertension Ek P, Toomik R, Eriksson S, Frithz G, Ronquist G, Engstrém L.
and non-insular-dependent diabetes mellitus (NIDDM). The Erythrocytic protein kinase C activity in primary hyperten-
Skaraborg Hypertension Project, 223 sion, 299
Boman Ks ee Weinehall L et al. EJ-Salhy M, Simonsson M, Stenling R, Grimelius L. Recovery from
Bonaa KH see Nordoy A et al. Marie-Bamberger’s syndrome and diabetes insipidus after
Bonardi G see Romeo G et al. removal of a lung adenocarcinoma with neuroendocrine fea-
Bredberg A see Sjéberg Ke t al. tures (Case report), 171
Brorson H see Berntorp Ee t al. Emmert-Buck MR see Marx SJ et al.
Burgess JR, Greenaway TM, Shepherd JJ. Expression of the MEN-1 Endre T, Mattiasson I, Berglund G, Hulthén UL. Muscle fibre com-
gene in a large kindred with multiple endocrine neoplasia position and glycogen synthase activity in hypertension-
type 1 (Minisymposium), 465 prone men, 141]
Engstr6ém L see Ek P et al.
Cabeda JM see Cardoso EMP et al. Ericson M see Jensen-Urstad M et al.
Cadiot G see Mignon M Ericsson C-G see Regnstrém J et al.
Campello C see Richard Se t al. Eriksson KF see Sjéberg K et al.
© 1998 Blackwell Science Ltd
596 AUTHOR INDEX
Eriksson M, Hadell K, Holme I, Walldius G, Kjellstrém T. Hansen J-B see Nordoy A et al.
Compliance with and efficacy of treatment with pravastatin Harbrecht U, Oldenburg J, Klein P, Weber D, Rockstroh J, Hanfland
and cholestyramine: a randomized study on lipid-lowering in P. Increased sensitivity of factor IX to phenprocoumon as a
primary care, 373 cause of bleeding in a patient with antiphospholipid antibody
Eriksson S see Ek P et al. associated thrombosis (Case report), 73
Eriksson S see Sjéberg K et al Hartford M see Berglin Blohm M et al.
Esin S see Cardoso EMP et al. Harvey CJ, Johnston JD. Cardiopathia fantastica exposed by rapid
sequential serum creatinine kinase analysis (Case report),
Faber J see Knudsen Ne t al 323
Facchini FS see Jeppesen J et al. Hedblad B, Janzon L, Jungquist G, Ogren M. Factors modifying the
Fellstrém B. Atherosclerosis: Usage and misusage (Reply to Letter prognosis in men with asymptomatic carotid artery disease,
to the Editor), 397 ay.
Ferrante L see Sgreccia A et al. Hegediis L see Knudsen N et al.
Filipowski H see Hruby Z et al. Heitz PU see Komminoth Pe t al.
Fisman EZ see Lev EI et al. Hellenius M-L see Regnstrém J et al.
Florén C-H, Ahrén B, Bengtsson M, Bartosik J, Obrant K. Bone Henriksson P see Karlberg K-E et al.
mineral density in patients with Crohn's disease during long- Heppner C see Marx SJ et al.
term treatment with azathioprine, 123 Herlitz J see Berglin Blohm M et al.
Forssmann W-G see Haller C et al. Herlitz J see Kristinsson JO et al.
Foster G see Wells PS et al. Herlitz J, Karlson BW, Lindqvist J, Sjolin M. Predictors and mode of
Franzson Ls ee Kristinsson JO et al. death over 5 years amongst patients admitted to the emer-
Frick K see Berntorp Ee t al. gency department with acute chest pain or other symptoms
Friedman EH. Neurobiology of the association of chronic work raising suspicion of acute myocardial infarction, 41
stress with atherogenic lipids and elevated fibrinogen in Hes FJ see Wittel-Post D et al.
middle-aged men (Letter to the Editor), 340 Hirsh J see Wells PS et al.
Frithz G see Ek P et al. Hirshberg B, Trelezky V, Raz I. Hypoglycaemia following pancreat-
Fuchs D see Samsonov M et al. ic allograft transplantation (Case report), 389
Fusco A see Santoro M et al. Hofland L] see Lamberts SW] et al.
Holm G. Journal of Internal Medicine: a journal in progress
Gansevoort RT see van der Kleij FGH et al. (Editorial), 1
Gartaganis S see Georgiou Se t al Holme I see Eriksson M et al.
Gasbarrini G see Capristo E et al. H6lzl B, Paulweber B, Sandhofer F, Patsch JR. Hypertriglyceridemia
Georgiou S, Monastirli A, Pasmatzi E, Gartaganis S, Goerz G, and insulin resistance (Case report), 79
Tsambaos D. Efficacy and safety of systemic recombinant Hoogerbrugge N, Jansen H, De Heide L, Zillikens MC, Deckers JW,
interferon-alpha in Behcet's disease, 367 Birkenhager JC. The additional effects of acipimox to simvas-
Ginsberg JS see Wells PS et al. tatin in the treatment of combined hyperlipidaemia
Girolami A see Wells PS et al. (Erratum), 403 (reprint from 241:151-156.)
Goerz G see Georgiou S et al. Hoogerbrugge N, Kerkhofs LGM, Jansen H. Gemfibrozil decreases
Goldfarb DA. Nephron-sparing surgery and renal transplantation autoantibodies against oxidized low-density lipoprotein in
in patients with renal cell carcinoma and von Hippel—Lindau men with combined hyperlipidaemia, 355
disease (Minisymposium), 563 Hruby Z, Smolska D, Filipowski H, Rabezyniski J, Cieslar E, Kopeé
Golubrovic¢ E see Stefanovicé V et al. W, Dulawa J. The importance of tubulointerstitial injury in
Gould D, Argiris A. Unilateral breast oedema as a manifestation of the early phase of primary glomerular disease, 215
congestive heart failure (Letter to the Editor), 328 Huhtasaari F see Weinehall L et al.
Greco AV see Capristo E al. Hultcrantz R see Cardoso EMP et al.
Greenaway TM see Burgess JR et al. Hulthén UL see EndreT et al.
Grimelius L see El-Salhy M et al.
Grundy SM see Mostaza JM et al. Ibrahim J see Davis TME et al.
Gunji A see Yanagibori R et al. Ikeda Y see Suga S et al.
Guru SC, Manickam P, Crabtree JS, Olufemi S-E, Agarwal SK, [liopoulos O see Kaelin WG et al.
Debelenko LV et al.. Identification and characterization of the Ingebretsen OC see Nordoy A et al.
multiple endocrine neoplasia type 1 (MEN 1) gene Intragumtornchai T, Rojnukkarin P, Swasdikul D, Israsena S. The
(Minisymposium), 433 role of serum ferritin in the diagnosis of iron deficiency
anaemia in patients with liver cirrhosis, 2 33
Hadell K see Eriksson M et al Isamail R see Davis TME et al.
Hagen K see Cardoso EMP et al. Israsena S see Intragumtornchai T et al.
Haller C, Meyer M, Scheele T, Koch A, Forssmann W-G, Kiibler W. Itakura H see Yanagibori R et al.
Radiocontrast-induced natriuresis associated with increased Ito S see Takahashi M et al.
urinary urodilation excretion, 155 IwamotoT see Yanagibori R et al.
Hallmans G see Weinehall L et al. Iwashita T see Takahashi M et al.
Hamsten A see Regnstrém J et al.
Hanfland P see Harbrecht U et al. Jackel E see Tietge UJF et al.
( 1998 Blackwell Science Ltd Journal of Internal Medicine 243: 595
AUTHOR INDEX a7
Jackson CE. A 50 year perspective on endocrine neoplasia: clinic to Kovithavongs C see Kjellstrand CM et al.
genes and back (Minisymposium), 419 Kreeftenberg HG see van der Kleij FGH et al.
Jansen H see Hoogerbrugge N et al. Kristinsson JO, Valdimarsson 0, Sigurdsson G, Franzson L,
Jansson J-H see Weinehall L et al. Olafsson I, Steingrimsdottir L, Herlitz J. Serum 2 5-hydroxy-
Janzon L see Hedblad Be t al. vitamin Dl evels and bone mineral density in 16—20-year-old
Jasonni V see Romeo G et al. girls: lack of association, 381
Jensen RT. Management of the Zollinger—Ellison syndrome in Kubler W see Haller C et al.
patients with multiple endocrine neoplasia type 1 Kuhn M see Canova CR et al.
(Minisymposium), 477
Jensen-Urstad K see Jensen-Urstad M et al. Lamberts SWJ, Hofland LJ, Lely AJVD, de Herder WW.
Jensen-Urstad M, Jensen-Urstad K, Ericson M, Johansson J. Heart Somatostatin receptor expression in multiple endocrine neo-
rate variability is related to leucocyte count in men and to plasia and in von Hippel—Lindau disease (Minisymposium),
blood lipoproteins in women in a healthy population of 35- 569
year old subjects, 33 Lely AJVD see Lamberts SWJ et al.
Jeppesen J, Facchini FS, Reaven GM. Individuals with high total Lensing AWA see Wells PS et al.
cholesterol/HDL cholesterol ratios are insulin resistant, 293 Lerone M see Romeo G et al.
Johansson J see Jensen-Urstad M et al. Lev EI, Pines A, Drory Y, Rotmensch HH, Tenenbaum A, Fisman
Johnson O see Weinehall L et al. EZ. Exercise-induced aortic flow parameters in early post-
Johnston JD see Harvey CJ menopausal women and middle-aged men, 275
Jolobe OMP. Cardiac tamponade preceding adrenal insufficiency Lindberg A see Sjoh6lm A et al.
an unusual presentation of Addison's disease (Letter to the Lindblad U see Bog-Hansen Ee t al.
Editor), 399 Lindergard B see Valdemarsson Se t al.
Jolobe OMP. Chlamydia pneumoniae (Letter to the Editor), 328 Lindqvist J see Herlitz J et al.
Jolobe OMP. Congestive heart failure in old age (Letter to the Lips CJM see Wittel-Post De t al.
Editor), 327 Lips CJM. Clinical management of the multiple endocrine neopla-
Jovinge S see Regnstrém Je t al. sia syndromes: Results of a computerized opinion poll at the
Jungquist G see Hedblad Be t al. Sixth International Workshop on Multiple Endocrine
Neoplasia and Von Hippel—Lindau Disease, 589
Kadir ZA see Davis TME et al. Lips CJM. Multiple endocrine neoplasia and von Hippel-Lindau dis-
Kaelin WG, Iliopoulos O, Lonergan KM, Obh M. Functions of the ease (Minisymposium), 41 ]
von Hippel—Lindau tumour suppressor protein Lofmark R, Nilstun T. Informing patients and relatives about do-
(Minisymposium), 535 not-resuscitate decisions. Attitudes of cardiologists and nurs-
Karlberg K-E, Saldeen T, Wallin R, Henriksson P, Nyquist O, Sylvén es in Sweden, 191
C. Intravenous nitroglycerin reduces ischaemia in unstable Lonergan KM see Kaelin WG et al.
angina pectoris: a double-blind placebo-controlled study, 25 Lopatin J see Samsonov M et al.
Karlson BW see Herlitz J et al. Lupoli G see Santoro M et al.
Karlsson T see Berglin Blohm M et al.
Kasai N see Suga Se t al. Maher ER see Richards FM et al.
Katsorida M see Archimandritis A et al. Manickam P see Guru SC et al.
Kawakubo K see Yanagibori Re t al. Maniwa K see Yanagawa H et al.
Kearon C see Wells PS et al. Manning WJ see Beattie JR et al.
Kerkhofs LGM see Hoogerbrugge Ne t al. Manns MPs ee Tietge UJF et al
Kester MB see Marx SJ et al. Mareev V see Samsonov Me t al.
Kim YS see Marx SJ et al. Martucciello G see Romeo et al.
Kinpara I see Suga S et al. Marx SJ, Agarwal SK, Kester MB, Heppner C, Kim YS, Emmert-
Kiwitt S see Sawicki PT et al. Buck MR et al. Germline and somatic mutation of the gene for
Kjellstrand CM, Kovithavongs C, Szabo E. On the success, cost and multiple endocrine neoplasia type 1 (Minisymposium), 447
efficiency of modern medicine: an international comparison, 3 Mattiasson I see EndrTe et al.
Kjellstrém T see Eriksson M et al. McMahon Rs ee Richards FM et al.
Klein P see Harbrecht U et al. Melander A see Bog-Hansen Ee t al.
Kléppel G see Komminoth Pe t al. Melillo RM see Santoro M et al.
Knudsen N, Faber J, Sierbaek-Nielsen A, Vadstrup S, S6rensen HA, Meyer M see Haller C et al.
Hegeditis L. Thyroid hormone treatment aiming at reduced, Mignon M, Cadiot G. Diagnostic and therapeutic criteria in
but not suppressed, serum thyroid-stimulating hormone lev- patients with Zollinger—Ellison syndrome and multiple
els in nontoxic goitre: effects on bone metabolism amongst endocrine neoplasia type 1 (Minisymposium), 489
premenopausal women, 149 Mingrone G see Capristo E. et al.
Koch A see Haller C et al. Miti¢-Zlatkovic M see Stefanovié V et al.
Komminoth P, Heitz PU, Kléppel G. Pathology of MEN-1: morphol- Miyata J see Yanagawa H et al.
ogy, clinicopathologic correlations and tumour development Moley JF, DeBenedetti MK, Dilley WG, Tisell LE, Wells SA. Surgical
(Minisymposium), 455 management of patients with persistent or recurrent
Kondo Ks ee Yanagibori Re t al. medullary thyroid cancer (Minisymposium) 521
Kopeé W see Hruby Z et al. Monastirli A see Georgiou Se t al.
© 1998 Blackwell Science Ltd Journal of Internal Medicine 243: 595-599
598 AUTHOR INDEX
Morelli S see Sgreccia A et al. Haemangioblastoma of the central nervous system in von
Mostaza JM, Vega GL, Snell P, Grundy SM. Abnormal metabolism Hippel—Lindau disease (Minisymposium), 547
of free fatty acids in hypertriglyceridaemic men: apparent Richards FM, Webster AR, McMahon R, Woodward ER, Rose §,
insulin resistance of adipose tissue, 265 Maher ER. Molecular genetic analysis of von Hippel—Lindau
Murakami H see Suga Se t al. disease (Minisymposium), 527
Murakami Hs ee Takahashi M et al. Rockstroh J see Harbrecht U et al.
Rojnukkarin P see Intragumtornchai T et al.
Nassonov E see Samsonov M et al. Romeo G, Ceccherini I, Celli J, Priolo M, Betsos N, Bonardi G, Seri
Neumann HPH, Bender BU. Genotype—phenotype correlations in M, Yin L, Lerone M, Jasonni V, Martucciello G. Association of
von Hippel—Lindau disease (Minisymposium), 541 multiple endocrine neoplasia type 2 and Hirschprung disease
Nieminen MS see Rossinen J et al. (Minisymposium), 515
Nilsen H see Nordoy et al. Ronquist G see Ek Pe t al.
Nilsson J see Regnstrém J et al. Rose S see Richards FM et al.
Nilstun T see Lofmark R Rossinen J, Partanen J, Stenius-Aarniala B, Nieminen MS.
Nordoy A, Bonaa KH, Nilsen H, Berge RK, Hansen J-B, Ingebretsen Salbutamol inhalation has no effect on myocardial ischaemia
OC et al.. Effects of Simvastatin and omega-3 fatty acids on arrhythmias and heart-rate variability in patients with coro-
plasma lipoproteins and lipid peroxidation in patients with nary artery disease plus asthma or chronic obstructive pul-
combined hyperlipidaemia, 163 monary disease, 361
Nyquist O see Karlberg K-E et al. Rotmensch HH see Lev EI et al.
Oberg K, Skogseid B. The ultimate biochemical diagnosis of Sakashita N see Yoshimatsu S-I et al
endocrine pancreatic tumours in MEN-1 (Minisymposium), Saldeen T see Karlberg K-E et al.
471 Salvatore G see Santoro M et al.
Obrant K see Florén C-H et al. Samsonov M, Lopatin J, Tilz GP, Artner-Dworzak E, Nassonov E,
Ogren M see Hedblad B et al. Mareev V, Belenkov J, Wachter H, Fuchs D. The activated
Ogushi F see Yanagawa H et al. immune system and the renin—angiotensin—aldosterone sys-
Ohh M see Kaelin WG et al. tem in congestive heart failure, 93
Olafsson I see Kristinsson JO et al. Sandhofer F see H6lzl B et al.
Oldenburg J see Harbrecht U et al. Santoro M, Melillo RM, Carlomagno F, Visconti R, De Vita G,
Olufemi S-E see Guru SC et al. Salvatore G, Lupoli G, Fusco A, Vecchio G. Molecular biology
Onuma Ts ee Suga Se t al. of the MEN2 gene (Minisymposium), 505
Sawicki PT, Berger M. Pharmacological treatment of diabetic
Parker F see Richards Se t al. patients with cardiovascular complications (Review), 181
Partanen J see Rossinen J et al. Sawicki PT, Kiwitt S, Bender R, Berger M. The value of QT interval
Pasmatzi E see Georgiou Se t al. dispersion for identification of total mortality risk in non-
Patsch JR see H6lzl Be t al. insulin-dependent diabetes mellitus, 49
Paulweber B see Hélzl Be t al. Scheele T see Haller C et al.
Pearson PL, Van der Luijt RB. The genetic analysis of cancer Schmidt HH-J see Tietge UJF et al.
(Minisymposium), 413 Scopinaro F see Sgreccia A et al.
Perrone C see Sgreccia A et all. Seri M see Romeo G et al.
Personne M see Sjohélm A et al. Sgreccia A, Morelli S, Ferrante L, Perrone C, De Marzio P, De
Pines A see Lev EI et al. Vincentis G, Scopinaro F. QT interval and QT dispersion in
Prandoni P see Wells PS et al. systemic sclerosis (scleroderma), 127
Priolo M see Romeo G et al. Shepherd JJ see Burgess JR et al.
Sierbeek-Nielsen A see Knudsen Ne t al.
Rabczyniski J see Hruby Z et al. Sigurdsson G see Kristinsson JO et al.
Ranstam J see Bog-Hansen Ee t al Simonsson M see El-Salhy M et al.
Rastam L see Bog-Hansen Ee t al. Singh B see Davis TME et al.
Raz I see Hirshberg Be t al. Sivertssen E see Reikvam Ae t al.
Reaven GM see Jeppesen J et al. Sjéberg K, Eriksson KF, Bredberg A, Wassmuth R, Eriksson S.
Regnstrom J, Jovinge S, Bavenholm P, Ericsson C-G, de Faire U, Screening for coeliac disease in adult insulin-dependent dia-
Hamsten A, Hellenius M-L, Nilsson J, Tornvall P. Helicobacter betes mellitus, 133
pylori seropositivity is not associated with inflammatory para- Sjohdlm A, Lindberg A, Personne M. Acute nutmeg intoxication
meters, ‘ipid concentrations and degree of coronary artery (Letter to the Editor), 329
disease, 109 Sjdlin M see Herlitz J et al.
Reikvam A, Abdelnoor M, Sivertssen E. Has hospital mortality Skogseid B see Oberg K
from acute myocardial infarction been markedly reduced Smolsak D see Hruby Ze t al.
since the introduction of thrombolytics and aspirin? 259 Snell P see Mostaza JM et al.
Reinhart WH see Canova CR et al. Sone S see Yanagawa He t al.
Reitsma WD see van der Kleij FGH et al. Sérensen HA see Knudsen Ne t al.
Resche F see Richard Se t al. Souyioultzis S see Archimandritis A et al.
Richard S, Campello C, Taillandier L, Parker F, Resche F. Speich R see Thurnheer R
1998 Blackwell Science Ltd Journal of Internal Medicine 243: 595-599
AUTHOR INDEX 599
Stal P see Cardoso EMP et al. Tsambaos D see Georgiou Se t al.
Stefanovic V, Golubrovi¢ E, Vlahovié P, Mitic-Zlatkovié M. Age- Tzivras M see Archimandritis A et al.
related changes in IL-12 production by peripheral blood
mononuclear cells (PBMC) (Letter to the Editor), 83 Uchino M see Yoshimatsu S-I et al.
Stehbens WE. Atherosclerosis: Usage and misusage (Letter to the
Editor), 395 Vadstrup S see Knudsen N et al.
Steingrimsdottir L see Kristinsson JO et al. Valdemarsson §, Lindergard B, Tibblin S, Bergenfelz A. Increased
Stenius-Aarniala B see Rossinen J et al. biochemical markers of bone formation and resorption in pri-
Stenling R see El-Salhy M et al. mary hyperparathyroidism with special reference to patients
Stratakis CA see Chrousos GP with mild disease, 115
Suda T see Suga S et al. Valdimarsson O see Kristinsson JO et al.
Suga M see Yoshimatsu S-I et al. van Dalen A see van Vroonhoven Th JMV
Suga S, Tamasawa N, Kinpara I, Murakami H, Kasai N, OnumaT, van der Kleij FGH, Gansevoort RT, Kreeftenberg HG, Reitsma WD.
Ikeda Y, Takagi A, Suda T. Identification of homozygous Imported rickettsioses: think of murine typhus (Case report),
lipoprotein lipase gene mutation in a woman with recurrent 177
aggravation of hypertriglyceridaemia induced by pregnancy, Van der Luijt RB see Pearson PL
(Case report) 317 van Vroonhoven Th JMYV, van Dalen A. Successful minimally inva-
Sulaiman SA see Davis TME et al. sive surgery in primary hyperparathyroidism after combined
Suzuki Y see Yanagawa H et al. preoperative ultrasound and computed tomography imaging
Suzuki Y see Yanagibori R et al. (Minisymposium), 581
Swasdikul D see Intragumtornchai T et al. Vecchio G see Santoro M et al.
Sylvén C see Karlberg K-E et al. Vega GL see Mostaza JM et al.
Szabo E see Kjellstrand CM et al. Visconti R see Santoro M et al.
Vlahovié P see Stefanovic V et al.
Tada S see Yoshimatsu S-I et al. Wachter H see Samsonov M et al.
Taillandier L see Richard Se t al. Wall S see Weinhall L et al.
Takagi A see Suga Se t al. Walldius G see Eriksson M et al.
Takahashi M, Asai N, Iwashita T, Murakami H, Ito S. Molecular Wallin R see Karlberg K-E et al.
mechanisms of development of multiple endocrine neoplasia Wassmuth R see Sjoberg K et al.
2 by RET mutations (Minisymposium), 509 Weber D see Harbrecht U et al.
Takeuchi E see Yanagawa H et al. Webster AR see Richards FM et al.
Tamasawa Ns ee Suga Se t al. Weinehall L, Johnson O, Jansson J-H, Boman K, Huhtasaari F,
Tenenbaum As ee Lev EI et al. Hallmans G, Dahlen GH, Wall S. Perceived health modifies
Terazaki H see Yoshimatsu S-I et al. the effect of biomedical risk factors in the prediction of acute
The European Consortium on MEN-1. The search for the MEN1 myocardial infarction. An incident case-control study from
gene (Minisymposium), 441 northern Sweden, 99
Theh BT. Thymic carcinoids in multiple endocrine neoplasia type 1 Weitz J see Wells PS et al.
(Minisymposium), 501 Wells PS, Hirsh J, Anderson DR, Lensing AWA, Foster G, Kearon C,
Thompson NW. Current concepts in the surgical management of Weitz J, D’'Ovidio R, Cogo A, Prandoni P, Girolami A, Ginsberg
multiple endocrine neoplasia type 1 pancreatic-duodenal dis- JS. A simple clinical model for the diagnosis of deep-vein
ease. Results in the treatment of 40 patients with thrombosis combined with impedance plethysmography: the
Zollinger-Ellison syndrome, hypoglycaemia or both potential for an improvement in the diagnostic process, 15
(Minisymposium), 495 Wells SA see Moley JF et al.
Thurnheer R, Speich R. Hyperthyroidism and pulmonary hyper- Werdan K. The activated immune system in congestive heart fail-
tension (Reply to Letter to the Editor), 399 ure — from dropsy to the cytokine paradigm (Editorial), 87
Tibblin S see Valdemarsson Se t al. Wittebol-Post D, Hes FJ, Lips CJM. The eye in von Hippel—Lindau
Tietge UJF, Schmidt HH-J, Jackel E, Trautwein C, Manns MP. Low disease. Long-term follow-up of screening and treatment:
molecular weight heparin-induced skin necrosis occurring recommendations (Minisymposium), 555
distant from injection sites and without thrombocytopenia Woodward ER see Richards FM et al.
(Case report), 313
Tilz GP see Samsonov M et al. Yamashita T see Yoshimatsu S-I et al.
Tisell LE see Moley JF et al. Yanagawa H, Takeuchi E, Miyata J, Maniwa K, Suzuki Y, Ogushi F,
Tonstad S. Do genetic determinates of ischaemic heart disease Sone S. Rheumatoid plerual effusion with detectable level of
imply that prevention may become more difficult? (Review), interleukin-15 (Letter to the Editor), 33
333 Yanagibori R, Kondo K, Suzuki Y, Kawakubo K, IwamotoT,
Toomik R see Ek Pe t al. Itakura H, Gunji A. Effect of 20 days’ bed rest on the reverse
Torfoss D. Cardiac tamponade preceding adrenal insufficiency — an cholesterol transport system in healthy young subjects, 307
unusual presentation of Addison's disease (Reply to Letter to Yin L see Romeo G et al.
the Editor), 399 Yoshimatsu S-I, Ando Y, Terazaki H, Sakashita N, Tada S,
Tornvall P see Regnstrém J et al. Yamashita T, Suga M, Uchino M, Ando M. Endoscopic and
Trautwein C see Tietge UJF et al. pathological manifestations of the gastrointestinal tract in
Trelizky V see Hirshberg Be t al. familial amyloidotic polyneuropathy type I (Met 30), 65
© 1998 Blackwell Science Ltd Journal of Internal Medicine 243: 595-599

Journal of Internal Medicine 1998; 243: 601-603
Keyword index
acute chest pain, 41 diabetes insipidus, 171
acute myocardial infarction, 99, 243 diabetes mellitus, 133, 181
acute phase reactant, 109 diagnostic tests, 233
adenocarcinoma, 171 diarrhoea, 251
adolescents, 381 digestive endocrine tumours, 489
adrenal, 465 DNA repair genes, 413
AL amyloidosis, 65 do-not-resuscitate orders, 191
aldosterone, 93 Doppler, 275
amyloid, 65 dual-energy X-ray absorptiometry (DEXA), 381
anaemia, 233 duodenal ulcer, 251
angina pectoris, 25
angiotensin, 93 echocardiography, 281
anticoagulation, 281 economy, 3
antiduretic hormone, 171 elongins, 535
antihypertensive treatment, 181 endocrine, 425
antiphospholipid antibody syndrome, 73 endomysial antibodies, 133
aortic flow, 275 enteropancreatic, 465
aphthae, 367 erythrocyte, 299
aspirin treatment, 259 euglycemic clamp technique, 141
asthma, 361 exercise, 275
azathioprine, 123 expenses, 3
bed rest, 307
factor IX, 73
Behcet's disease, 367 familial MEN syndromes, 425
biomedical risk factors, 99
family history of hypertension, 141
bone formation, 115 FAP, 65
bone metabolism, 149 fat weight, 265
bone mineral density, 123, 381
fatty acids, 265
calcium intake, 381 fibrinogen, 197
cancer genetics, 413
cardiac mortality, 49 gastrointestinal tract, 65
cardiopathia fantastica, 323 gemfibrozil, 355
cardiovascular disease, 181 genetics, 419
cardiovascular risk factors, 33 genotype, 203
carotid artery, 57 genotype—phenotype correlations, 541
gliadin antibodies, 133
cerebrovascular mortality, 49
glomerulopathy, 215
cholesterol ester transfer protein, 307
cholesterol, 293, 373 glycogen synthase, 141
cholesterol-HDL ratio, 293 goitre, 149
cholestyramine, 373 gross domestic product, 3
chronic obstructive pulmonary disease, 361
citrate clamp, 349 haemochromatosis, 203
clarithromycin, 251 HDL-cholesterol, 265, 293, 307
heart disease, 323
clinical management, 581
heart rate variability, 33, 127, 361
Clostridium difficile, 251
Helicobacter pylori eradication therapy, 251
clustering, 223
coeliac disease, 133 Helicobacter pylori, 109
colitis, 251 heparin, 313
hereditary cancer, 413
combined hyperlipidemia, 163
compliance, 373 hereditary tumour syndromes, 541
HFE, 203
computerized opinion poll, 581
hospital mortality, 259
congestive heart failure, 93
human, 155
coronary angiography, 109, 155
coronary artery disease, 109, 361 hyperparathyroidism, 419, 465
hypertension, 223, 299
corticosteroids, 123
Crohn’s disease, 123, 339 hypertriglyceridemia, 79, 317
hypocalcaemia, 349, 389
delay, 243
Dercum’s disease, 197 IDDM, 133
© 1998 Blackwell Science Ltd
602 KEYWORD INDEX
immune activation, 93
impedance plethysmography, 15 pancreatitis, 317
parathormone, 349
inflammation, 109
inflammatory bowel disease, 339 parathyroid hormone, 115
patients, 191
information, 191
perceived health, 99
inherited disorders, 203
insulin resistance, 79, 141, 265. 29 3 pphhaeknopmraotcoosuemso,n ,4 257 3
insulin sensitivity, 197
phlebography, 15
interferon-a, 367
interstitial morphometry, 215 physicians, 191
iron deficiency, 233 pituitary, 465
iron, 203 placebo-controlled, 25
platelets, 25
irregular heart beat, 209
population study, 33
LDL cholesterol, 293 post-menopausal, 275
LDL size, 355 pravastatin, 373
lecithin-cholesterol acyltransferase, 307 prednisolone, 123
life expectancy, 3 pregnancy, 317
lipid peroxides, 163 prevalence, 133
lipid-lowering, 373 primary health care, 223
lipoprotein lipase deficiency, 79, 317 primary hyperparathyroidism, 115. 489
lipoprotein lipase, 307 primary-care, 373
liposuction, 197 protein kinase C, 299
liver cirrhosis, 233 proto-oncogenes, 413
long-term prognosis, 41 pulmonary artery hypertension, 255
lung, 171 pulmonary embolism, 255
malaria, 349 QT interval, 49, 127
Marie-Bamberger's syndrome, 171
MEN-1, 465, 489 radiocontrast, 155
metronidazole, 251] relatives, 19]
mortality, 3, 41 renin, 93
multiple endocrine neoplasia, 419, 569, 581 Rickettsia typhii, 177
multistep process, 413 rickettsioses, 177
Munchausen’s syndrome, 323 risk factors, 41, 49, 223
murine typhus, 177
muscle fibre type, 141 Saccharomyces boulardii, 251
myocardial infarction, 259, 323 salbutamol, 361
myocardial ischaemia, 361 screening, 465
secondary amyloidosis, 65
natriuretic peptides, 155 serum ferritin, 233
necrosis, 313 serum lipids, 163
nephropathy, 181] sex, 373
nested case-control tudy, 99 side effects, 313
neuroendocrine differentiation, 17] Simvastatin, 163
neurofibromatosis, 425 skeletal disease, 115
NIDDM, 223 skin, 313
nightmare, 209 sleep, 209
nitroglycerin, 25 smoking, 181
nocturnal awakening, 209 somatostatin receptors, 569
non-insulin-dependent diabetes mellitus, 49 spasmodic chest pain, 209
nurses, 191] stroke, 28]
substrate oxidation, 339
omega-3 fatty acids, 163 systemic sclerosis, 127
oral anticoagulant therapy, 73
oral antidiabetic agents, 18] thrombolytic therapy, 243
osteocalcin, 115 thrombolytic treatment, 259
outcome, 3 thrombophlebitis, 15
oxidation, 355 thrombosis, 15
thyroid hormones, 149
PAI-1, 197 total mortality, 49
pancreatic transplantation, 389 transthyretin, 65
treatment goals, 223
E 1998 Blackwell Science Ltd Journal of Internal Medicine 243: 601-603
KEYWORD INDEX
triglyceride, 307, 355 ultrasound, 57, 149
triglycerides, 265
tubular function, 215 Vitamin D, 381
tubulointerstitium, 215 Vitamin D-receptor genotypes (VDR), 381
tumour embolism, 255 VLDL-apo B, 265
tumour suppressor gene, 535 von Hippel—Lindau disease, 425, 535, 541, 569, 581
tumour suppressor genes, 413 VWF:Ag, 197
tumour suppressor protein, 535
woman, 209
ulcerative colitis, 339
ultra-levure, 251
Zollinger—Ellison syndrome, 489
© 1998 Blackwell Science Ltd Journal of Internal Medicine 243: 601-603